HC Wainwright Increases Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $500.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) had its target price upped by stock analysts at HC Wainwright from $400.00 to $500.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the biopharmaceutical company’s stock. HC Wainwright’s price target suggests a potential upside of 103.92% from […]
